P3 Health Partners Stock Fundamentals
| PIIIW Stock | USD 0.02 0 20.00% |
P3 Health Partners fundamentals help investors to digest information that contributes to P3 Health's financial success or failures. It also enables traders to predict the movement of PIIIW Stock. The fundamental analysis module provides a way to measure P3 Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to P3 Health stock.
At this time, P3 Health's Depreciation And Amortization is fairly stable compared to the past year. Reconciled Depreciation is likely to climb to about 105.1 M in 2025, whereas Interest Expense is likely to drop slightly above 17.5 M in 2025. PIIIW | Select Account or Indicator |
P3 Health Partners Company Return On Equity Analysis
P3 Health's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current P3 Health Return On Equity | -0.65 |
Most of P3 Health's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, P3 Health Partners is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
PIIIW Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, P3 Health Partners has a Return On Equity of -0.6545. This is 97.27% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is 111.13% higher than that of the company.
P3 Health Partners Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining P3 Health's current stock value. Our valuation model uses many indicators to compare P3 Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across P3 Health competition to find correlations between indicators driving P3 Health's intrinsic value. More Info.P3 Health Partners is regarded fourth in return on equity category among its peers. It is regarded third in return on asset category among its peers . At this time, P3 Health's Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value P3 Health by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.PIIIW Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses P3 Health's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of P3 Health could also be used in its relative valuation, which is a method of valuing P3 Health by comparing valuation metrics of similar companies.P3 Health is currently under evaluation in return on equity category among its peers.
PIIIW Fundamentals
| Return On Equity | -0.65 | ||||
| Return On Asset | -0.18 | ||||
| Profit Margin | (0.07) % | ||||
| Operating Margin | (0.31) % | ||||
| Number Of Shares Shorted | 11.72 K | ||||
| Revenue | 1.27 B | ||||
| Gross Profit | (40.2 M) | ||||
| EBITDA | (81.07 M) | ||||
| Net Income | (57.77 M) | ||||
| Cash And Equivalents | 4.34 M | ||||
| Cash Per Share | 0.10 X | ||||
| Total Debt | 121.94 M | ||||
| Current Ratio | 0.45 X | ||||
| Book Value Per Share | 0.74 X | ||||
| Cash Flow From Operations | (76.03 M) | ||||
| Earnings Per Share | (1.34) X | ||||
| Number Of Employees | 400 | ||||
| Beta | 0.95 | ||||
| Total Asset | 860.97 M | ||||
| Retained Earnings | (367.34 M) | ||||
| Working Capital | (133.35 M) | ||||
| Net Asset | 860.97 M |
About P3 Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze P3 Health Partners's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of P3 Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of P3 Health Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -2.4 M | -2.3 M | |
| Total Revenue | 1.5 B | 1.4 B | |
| Cost Of Revenue | 1.4 B | 826.5 M | |
| Sales General And Administrative To Revenue | 0.11 | 0.19 | |
| Revenue Per Share | 12.01 | 11.41 | |
| Ebit Per Revenue | (0.15) | (0.16) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for PIIIW Stock Analysis
When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.